1. Home
  2. BOLD vs CLIR Comparison

BOLD vs CLIR Comparison

Compare BOLD & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • CLIR
  • Stock Information
  • Founded
  • BOLD 2018
  • CLIR 2008
  • Country
  • BOLD United States
  • CLIR United States
  • Employees
  • BOLD N/A
  • CLIR N/A
  • Industry
  • BOLD
  • CLIR Industrial Machinery/Components
  • Sector
  • BOLD
  • CLIR Industrials
  • Exchange
  • BOLD Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • BOLD 24.4M
  • CLIR 27.9M
  • IPO Year
  • BOLD 2024
  • CLIR 2012
  • Fundamental
  • Price
  • BOLD $1.15
  • CLIR $0.54
  • Analyst Decision
  • BOLD Buy
  • CLIR Strong Buy
  • Analyst Count
  • BOLD 3
  • CLIR 1
  • Target Price
  • BOLD $4.00
  • CLIR $2.00
  • AVG Volume (30 Days)
  • BOLD 277.1K
  • CLIR 55.2K
  • Earning Date
  • BOLD 08-11-2025
  • CLIR 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • CLIR N/A
  • EPS Growth
  • BOLD N/A
  • CLIR N/A
  • EPS
  • BOLD N/A
  • CLIR N/A
  • Revenue
  • BOLD N/A
  • CLIR $2,895,000.00
  • Revenue This Year
  • BOLD N/A
  • CLIR $27.61
  • Revenue Next Year
  • BOLD N/A
  • CLIR $116.19
  • P/E Ratio
  • BOLD N/A
  • CLIR N/A
  • Revenue Growth
  • BOLD N/A
  • CLIR 10.88
  • 52 Week Low
  • BOLD $1.00
  • CLIR $0.46
  • 52 Week High
  • BOLD $4.72
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • CLIR 40.91
  • Support Level
  • BOLD N/A
  • CLIR $0.50
  • Resistance Level
  • BOLD N/A
  • CLIR $0.60
  • Average True Range (ATR)
  • BOLD 0.00
  • CLIR 0.05
  • MACD
  • BOLD 0.00
  • CLIR -0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • CLIR 35.73

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: